IL161710A0 - Macrolides - Google Patents

Macrolides

Info

Publication number
IL161710A0
IL161710A0 IL16171002A IL16171002A IL161710A0 IL 161710 A0 IL161710 A0 IL 161710A0 IL 16171002 A IL16171002 A IL 16171002A IL 16171002 A IL16171002 A IL 16171002A IL 161710 A0 IL161710 A0 IL 161710A0
Authority
IL
Israel
Prior art keywords
macrolides
Prior art date
Application number
IL16171002A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Inst D O O filed Critical Glaxo Group Ltd
Publication of IL161710A0 publication Critical patent/IL161710A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
IL16171002A 2001-11-14 2002-11-13 Macrolides IL161710A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0127349.9A GB0127349D0 (en) 2001-11-14 2001-11-14 Macrolides
PCT/GB2002/005101 WO2003042228A1 (en) 2001-11-14 2002-11-13 Macrolides

Publications (1)

Publication Number Publication Date
IL161710A0 true IL161710A0 (en) 2004-09-27

Family

ID=9925777

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16171002A IL161710A0 (en) 2001-11-14 2002-11-13 Macrolides

Country Status (20)

Country Link
US (1) US7202221B2 (ru)
EP (1) EP1453846B1 (ru)
JP (1) JP2005515978A (ru)
CN (1) CN1307194C (ru)
AR (1) AR037371A1 (ru)
AT (1) ATE362479T1 (ru)
BR (1) BR0214132A (ru)
CA (1) CA2466975A1 (ru)
DE (1) DE60220180T2 (ru)
EA (1) EA007433B1 (ru)
ES (1) ES2287332T3 (ru)
GB (1) GB0127349D0 (ru)
HR (1) HRP20040433A2 (ru)
HU (1) HUP0402225A3 (ru)
IL (1) IL161710A0 (ru)
PL (1) PL371472A1 (ru)
RS (1) RS41904A (ru)
UA (1) UA77210C2 (ru)
WO (1) WO2003042228A1 (ru)
ZA (1) ZA200403684B (ru)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
WO2005070918A1 (en) 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
DK1503759T3 (da) * 2002-05-14 2009-04-14 Univ California Substituerede quinoloncarboxylsyrer, deres derivater, virkningssted og anvendelser heraf
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310986D0 (en) 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
DK1628989T3 (da) * 2003-05-13 2007-10-08 Glaxo Group Ltd Hidtil ukendte, 14- og 15-leddet ring-forbindelser
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US7265094B2 (en) 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
WO2005085266A2 (en) 2004-02-27 2005-09-15 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
JP2007536371A (ja) * 2004-05-06 2007-12-13 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 微生物感染症の治療に有用なエステル結合マクロライド
WO2005108413A1 (en) * 2004-05-06 2005-11-17 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O Carbamate linked macrolides useful for the treatment of microbial infections
WO2006047167A2 (en) * 2004-10-21 2006-05-04 Janssen Pharmaceutica, N.V. 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424951D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424959D0 (en) 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
JP5254231B2 (ja) 2006-08-09 2013-08-07 バジリア ファルマスーチカ アーゲー 炎症性及びアレルギー性疾患に対して有用な新規マクロライド
CA2661538A1 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
JP5651019B2 (ja) 2008-02-08 2015-01-07 バジリア ファルマスーチカ アーゲーＢａｓｉｌｅａ Ｐｈａｒｍａｃｅｕｔｉｃａ ＡＧ 新規マクロライドおよびそれらの使用
JP5607149B2 (ja) 2009-05-27 2014-10-15 ウォックハート リサーチ センター 抗菌活性を有するケトライド化合物
AU2011340204B2 (en) 2010-12-09 2016-04-14 Wockhardt Limited Ketolide compounds
KR20140004187A (ko) * 2011-01-31 2014-01-10 메이지 세이카 파루마 가부시키가이샤 신규 마크로라이드 유도체
US9206214B2 (en) 2011-03-01 2015-12-08 Wockhardt Ltd. Process for preparation of ketolide intermediates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126344A2 (en) 1983-05-20 1984-11-28 Abbott Laboratories Tripeptide esters of therapeutic agents
US4742049A (en) 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
NZ233117A (en) 1989-03-28 1991-05-28 Abbott Lab 9-deoxo-9,12-epoxy-erythromycin derivatives and pharmaceutical compositions
CA2064634C (en) 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
AU726075B2 (en) 1996-05-07 2000-10-26 Abbott Laboratories 6-o-substituted erythromycin compounds and method for making same
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
US6262030B1 (en) 1998-11-03 2001-07-17 Pfizer Inc. Erythromycin derivatives
KR20020016799A (ko) 1999-05-24 2002-03-06 데이비드 존 우드 13-메틸-에리트로마이신 유도체
EP1206476B1 (en) 1999-08-24 2006-01-04 Abbott Laboratories 9a-azalides with antibacterial activity
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
ES2254389T3 (es) 2000-02-24 2006-06-16 Abbott Laboratories Agentes anti-infecciosos utiles contra cepas bacterianas resistntes a multiples farmacos.
JP2002173498A (ja) 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
GB0025688D0 (en) 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
US20050080025A1 (en) 2005-04-14
EA007433B1 (ru) 2006-10-27
EA200400536A1 (ru) 2004-12-30
HRP20040433A2 (en) 2005-04-30
WO2003042228A1 (en) 2003-05-22
PL371472A1 (en) 2005-06-13
CN1612888A (zh) 2005-05-04
UA77210C2 (en) 2006-11-15
ZA200403684B (en) 2005-09-13
BR0214132A (pt) 2004-09-14
DE60220180T2 (de) 2008-01-17
JP2005515978A (ja) 2005-06-02
CA2466975A1 (en) 2003-05-22
ATE362479T1 (de) 2007-06-15
HUP0402225A3 (en) 2006-01-30
GB0127349D0 (en) 2002-01-02
ES2287332T3 (es) 2007-12-16
RS41904A (en) 2006-10-27
DE60220180D1 (de) 2007-06-28
CN1307194C (zh) 2007-03-28
HUP0402225A2 (hu) 2005-02-28
EP1453846B1 (en) 2007-05-16
AR037371A1 (es) 2004-11-03
US7202221B2 (en) 2007-04-10
EP1453846A1 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
GB0127349D0 (en) Macrolides
DE60213216D1 (en) Metalloproteinaseinhibitoren
IL157974A0 (en) Pesticidal macrolides
AU2002360430A8 (en) 14-methyl-epothilones
HU0400176V0 (en) Improved gasketseal
GB0108534D0 (en) Retaining means
AU2002313943A8 (en) Electromobile
GB0108110D0 (en) Keeps
GB0127345D0 (en) Macrolides
GB0126277D0 (en) Macrolides
GB0127351D0 (en) Macrolides
GB0127369D0 (en) Macrolides
GB0127352D0 (en) Macrolides
GB2376939B (en) Retaining means
AU2001100134A4 (en) Enviro-trap
GB0025689D0 (en) Macrolides
GB0031309D0 (en) Macrolides
GB0025691D0 (en) Macrolides
GB0025685D0 (en) Macrolides
GB0031313D0 (en) Macrolides
GB0031311D0 (en) Macrolides
GB0031314D0 (en) Macrolides
GB0025683D0 (en) Macrolides
GB0025687D0 (en) Macrolides
GB0031306D0 (en) Macrolides